United States · FDA National Drug Code directory
Meloxicam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 53225-3075_5475fe8e-f544-b38a-e063-6394a90adbff
- Product NDC
- 53225-3075
- Form
- TABLET
- Composition / generic term
- Meloxicam
- Labeler
- Terrain Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251020
- Source listing expiry
- 20271231
Source-listed ingredients
- MELOXICAM — 7.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (53225-3075-1) · 53225-3075-1
- 60 TABLET in 1 BOTTLE (53225-3075-2) · 53225-3075-2
- 90 TABLET in 1 BOTTLE (53225-3075-3) · 53225-3075-3
- 100 TABLET in 1 BOTTLE (53225-3075-4) · 53225-3075-4
- 120 TABLET in 1 BOTTLE (53225-3075-5) · 53225-3075-5
- 500 TABLET in 1 BOTTLE (53225-3075-6) · 53225-3075-6
- 1000 TABLET in 1 BOTTLE (53225-3075-7) · 53225-3075-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →